Volume 24, Issue 5 (September-October 2019)

REVIEW ARTICLES

The role of miRNA -31-3p and miR-31-5p in the anti-EGFR treatment efficacy of wild-type K-RAS metastatic colorectal cancer. Is it really the next best thing in miRNAs?

Daniel Sur, Simona Sorana Cainap, Claudia Burz, Andrei Havasi, Irina Camelia Chis, Catalin Vlad, Vladan Milosevic, Ovidiu Balacescu, Alexandru Irimie; pp 1739-1746 (Pubmed Abstract, PDF)

Evaluation of quality of life outcomes following palliative radiotherapy in bone metastases: A literature review

Christina Koufopoulou, Eftychia Mosa, Nikolaos Charalampakis, Michail Nikolaou, Nikolaos Tsoukalas, Ioanna Nixon, Haytham Hamed Saraireh, Jiannis Hajiioannou, Dimitrios Kardamakis,  George Kyrgias, Maria Tolia; pp 1747-1760 (Pubmed Abstract, PDF)

Current role of lymphadenectomy in gastric cancer surgery

Dimitrios Symeonidis, Alexandros Diamantis, Konstantinos Tepetes,  Effrosyni Bompou; pp 1761-1767 (Pubmed Abstract, PDF)

Impact of enterococcal urinary tract infections in immunocompromised – neoplastic patients

Xenofon Giannakopoulos, Hercules Sakkas, Vasileios Ragos, Evangelos Tsiambas, Petros Bozidis, Angelos M. Evangelou, Chrissanthy Papadopoulou, Leonidas Petrogiannopoulos, Nikolaos Sofikitis; pp 1768-1775 (Pubmed Abstract, PDF)

Primary squamous cell carcinoma of the ovary. Review of the literature

Nektarios Koufopoulos, Despoina Nasi, Christina Goudeli, Foteini Antoniadou, Stefania Kokkali, Eleni Pigadioti, Ioannis Provatas, Elpida Magou, Alexandros Ardavanis, Emmanouil Terzakis, Evdokia Arkoumani, Niki J. Agnantis, Nikiforos Apostolikas, Lubna Khaldi; pp 1776-1784 (Pubmed Abstract, PDF)

Current and future targets and therapies in metastatic colorectal cancer

Miljana Dzunic, Ivan Petkovic, Ana Cvetanovic, Svetislav Vrbic, Ivica Pejcic; pp 1785-1792 (Pubmed Abstract, PDF)

Diaphragmatic hernia following esophagectomy for esophageal cancer: A systematic review

Mairead M. Hennessy, Ivan Ivanovski, Eleftherios Spartalis, Dimosthenis Chrysikos, Antonios Athanasiou; pp 1793-1800 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

COLORECTAL CANCER

Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis

Abdullah Sakin, Suleyman Sahin, Muhammed Mustafa Atci, Nurgul Yasar, Caglayan Geredeli, Serkan Aribal, Ali Alemdar, Fatih Karatas, Sener Cihan; pp 1801-1808 (Pubmed Abstract, PDF)

Outcomes of conversion from laparoscopy to open surgery 

in geriatric patients with colorectal cancer: a case-control study

Nuri Okkabaz, Merih Yilmaz, Osman Civil, Mustafa Haksal, Mustafa Oncel; pp 1809-1816 (Pubmed Abstract, PDF)

Comparison of efficacy between natural orifice specimen extraction without abdominal incision and conventional laparoscopic surgery in the treatment of sigmoid colon cancer and upper rectal cancer

Yi Ding, Zenan Li, Haiting Gao, Yu Cao, Weisen Jin; pp 1817-1823 (Pubmed Abstract, PDF)

Evodiamine exerts anticancer effects via induction of apoptosis and autophagy and suppresses the migration and invasion of human colon cancer cells

Dan Wang, Shuke Ge, Zhe Chen, Yongwei Song; pp. 1824-1829 (Pubmed Abstract, PDF)

The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer

Aifeng Gong, Ziming Huang, Hengfa Ge, Yong Cai, Chenchen Yang; pp 1830-1836 (Pubmed Abstract, PDF)

Effect of PD98059 on chemotherapy in patients with colorectal cancer through ERK1/2 pathway

Yinpeng Li, Qiu Yang; pp 1837-1844 (Pubmed Abstract, PDF)

Comparison of clinicopathological and survival features of 

right and left colon cancers

Kaan Helvaci, Emrah Eraslan, Fatih Yildiz, Gulnihal Tufan, Umut Demirci, Omur Berna Oksuzoglu, Ulku Yalcintas Arslan; pp 1845-1851 (Pubmed Abstract, PDF)

Surgical and survival outcomes of laparoscopic colectomy for transverse colon cancer in elderly patients 

Meng Yue, Yue Wang, Zhen-Hua Kang, Xu Wang, Lei Wang; pp 1852-1860 (Pubmed Abstract, PDF)

Impact of neutrophil-lymphocyte and platelet-lymphocyte ratio on antiEGFR and bevacizumab efficacy in metastatic colorectal cancer

Ender Dogan, Oktay Bozkurt, Teoman Sakalar, Sumeyra Derin, Mevlude Inanc, Metin Ozkan; pp 1861-1869 (Pubmed Abstract, PDF)

Berbamine exerts anticancer effects on human colon cancer cells via induction of autophagy and apoptosis, inhibition of cell migration and MEK/ERK signalling pathway

Lianjun Mou, Bingyu Liang, Guanjun Liu, Junjun Jiang, Jie Liu, Bo Zhou, Jiegang Huang, Ning Zang, Yanyan Liao, Li Ye, Hao Liang; pp 1870-1875 (Pubmed Abstract, PDF)

BREAST CANCER

Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

Zeynep Oruc, Muhammet Ali Kaplan, Caglayan Geredeli,Nilgun Yildirim Sari,Ersin Ozaslan,Aydin Aytekin,Emin Tamer Elkiran,Sinan Koca,Mutlu Dogan,Nedim Turan,Ozlem Yuce,Alper Sevinc,Ozlem  Ercelep,Abdurrahman Isikdogan; pp 1876-1883 (Pubmed Abstract, PDF)

Blood groups type linked to breast cancer in a Greek cohort of women – a case control study

Anastasia Bothou, Panagiotis Tsikouras, Stefanos Zervoudis, George Tsatsaris, George Anastasopoulos, George Iatrakis, Katerina Lykeridou, Dorelia Deuteraiou, Xanthoula Anthoulaki, Anna Chalkidou, George Galazios; pp 1884-1888 (Pubmed Abstract, PDF)

Anaplastic large-cell periprosthetic lymphoma of the breast: could fibrin be an early radiological indicator of the presence of disease?

Daniele La Forgia, Marco Moschetta, Alfonso Fausto, Daniela Cutrignelli, Rosalba Dentamaro, Liliana Losurdo1 Arianna Maiorell4, Maurizio Ressa, Anna Scattone, Michele Telegrafo, Aurelio Portincasa; pp 1889-1897 (Pubmed Abstract, PDF)

Clinical significance of breast-conserving surgery for early breast cancer and its impact on patient quality of life

Ziliang Wang, Xiaoting Han; pp 1898-1904 (Pubmed Abstract, PDF)

miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10

Fei Liu, Liang Zhuang, Ruxing Wu, Dingyu Li; pp 1905-1912 (Pubmed Abstract, PDF)

Evaluation of plasma and tissue expression levels of Endothelins (ET-1, Big ET-1) and VEGF in lobular neoplasia of the breast

Vasileios Kalles, Ioannis Papapanagiotou, Maria Matiatou, Georgia Georgiou, Charalampos Theodoropoulos, Tania Triantafyllou, Eleni Zografos, Apostolos Mitrousias, Xeni Provatopoulou, Nikolaos V. Michalopoulos; pp 1913-1919 (Pubmed Abstract, PDF)

PTEN loss is a predictive marker for HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Kemal Tekesin, Mehmet Emin Gunes, Savas Bayrak, Emre Akar, Tulin Ozturk, Serdar Altinay, Deniz Tural; pp 1920-1926 (Pubmed Abstract, PDF)

Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population

Dalia Ivette Carrillo-Moreno, Luis Eduardo Figuera, Guillermo M. Zuniga-González, Ana Maria Puebla-Perez, Andres de Jesus Moran-Mendoza, Martha Patricia Gallegos-Arreola; pp 1927-1933 (Pubmed Abstract, PDF)

LIVER CANCER

Survivin expression in hepatocellular carcinoma. Correlation with clinicopathological characteristics and overall survival

Ioannis Kapiris, Konstantinos Nastos, Anestis Karakatsanis, Theodosios Theodosopoulos, Despoina Karandrea, Agatha Kondi-Pafiti, John Contis; pp 1934-1942 (Pubmed Abstract, PDF)

A comparative study of laparoscopic precise hepatectomy with conventional open hepatectomy in the treatment of primary hepatocellular cancer

Fei Luo, Jiaojun Zhou, Wei Yan; pp 1943-1949 (Pubmed Abstract, PDF)

Psoralidin inhibits the proliferation of human liver cancer cells by triggering cell cycle arrest, apoptosis and autophagy and inhibits tumor growth in vivo

Jia Li, Yongming Fu, Xingwang Hu, Yinghui Xiong; pp 1950-1955 (Pubmed Abstract, PDF)

Efficacy of apatinib in advanced hepatocellular carcinoma with lung metastasis: a retrospective, multicenter study

Xiuju Du, Diyao Chen, Zhenwen Lin, Zhongyi Dong, Yuwen Lu, Li Liu, Dehua Wu; pp 1956-1963 (Pubmed Abstract, PDF)

Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway

Chao Gao, Xuehua Li, Shuangshuang Yu, Liang Liang; pp 1964-1969 (Pubmed Abstract, PDF)

Endpoint of embolization: A study of transarterial chemoembolization in patients with large hepatocellular carcinoma

Hao Zhang, Yuandong Sun, Huirong Xu, Jingzhou Liu, Huizhuan Zhai, Changyan Lu, Xia Zhao, Yeqiang Chen, Linlin Zhou, Jianjun Han; pp 1970-1978 (Pubmed Abstract, PDF)

Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on prognosis and quality of life in primary chronic HBV-related liver cancer

Baoling Lu, Liying Zhu, Xiaofang Wang, Lihua Zhong, Yu Cheng, Jian Fang, Lei Yu; pp 1979-1984 (Pubmed Abstract, PDF)

GASTRIC CANCER

Apatinib suppresses the proliferation and apoptosis of gastric cancer cells via the PI3K/Akt signaling pathway

Xiaoqiong Jia, Zhenping Wen, Qiuying Sun, Xiaohua Zhao, Hao Yang, Xiaoyu Shi, Tao Xin; pp 1985-1991 (Pubmed Abstract, PDF)

The prognostic value of the change in neutrophil-to-lymphocyte ratio during first-line palliative chemotherapy in patients with metastatic gastric cancer: A retrospective study

Oktay Bozkurt, Sedat Tarik Firat, Ender Dogan, Ramazan Cosar, Mevlude Inanc, Metin Ozkan; pp 1992-1999 (Pubmed Abstract, PDF)

Antiproliferative activity of plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) in human gastric carcinoma cells is facilitated via activation of autophagic pathway, mitochondrial-mediated programmed cell death and inhibition of cell migration and invasion
Xiuli Ma, Xiuping Yin, Hu Liu, Qingming Chen, Yuanzhong Feng, Xiaoyun Ma, Weichang Liu; pp 2000-2005 (Pubmed Abstract, PDF)

A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer

Qingping Tai, Hua Shao, Yanli Liu, Enshan Li, Rongfei Zhao; pp 2006-2012 (Pubmed Abstract, PDF)

GYNECOLOGIC CANCER

Research on the efficacy of cisplatin and nimotuzumab combined with concurrent chemoradiotherapy on locally advanced cervical cancer

Ye Cao, Li Deng, Shixian Lian, Ying Jiang; pp 2013-2019 (Pubmed Abstract, PDF)

Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type

Triada Doulgeraki, Stylianos Vagios, Evangelia Kavoura, Petros Yiannou, Irini Messini, Afroditi Nonni, Christos Papadimitriou, Athanassios Vlachos,  Kitty Pavlakis; pp 2020-2027 (Pubmed Abstract, PDF)

Implementation of intensity-modulated radiotherapy and comparison with three-dimensional conformal radiotherapy in the postoperative treatment of cervical cancer

Dragoslava Marjanovic, Vesna Plesinac Karapandzic, Suzana Stojanovic Rundic, Aleksandar Tomasevic, Milan Saric, Ivana Miskovic, Borko Nidzovic, Mirjana Mikovic, Predrag Petrasinovic; pp 2028-2034 (Pubmed Abstract, PDF)

Neoadjuvant chemotherapy combined with interval debulking surgery in ovarian cancer

Xiaojie Lin, Xinjie Du; pp 2035-2040 (Pubmed Abstract, PDF)

HEAD & NECK CANCERS

Clinical stage of laryngeal carcinoma and lost time at the moment of diagnosis with 15-year-long interval. Are there any changes?

Danijela Dragicevic, Blagoje Andjelic, Rajko M. Jovic,  Vladimir Kljajic, Ljiljana Vlaski, Slobodan Savovic; pp 2041-2048 (Pubmed Abstract, PDF)

MicroRNA-299 targets VEGFA and inhibits the growth, chemosensitivity and invasion of human nasopharyngeal carcinoma cells

Jia Chen, Fukai Lu, Chunmei Hu; pp 2049-2055 (Pubmed Abstract, PDF)

Targeted antitumor activity of Ginsenoside (Rg1) in paclitaxel-resistant human nasopharyngeal cancer cells are mediated through activation of autophagic cell death, cell apoptosis, endogenous ROS production, S phase cell cycle arrest and inhibition of m-TOR/PI3K/AKT signalling pathway

Wei Li, Guangyi Li, Wensheng She, Xian Hu, Xingyu Wu; pp 2056-2061 (Pubmed Abstract, PDF)

Acetylshikonin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant oral cancer cells by inducing autophagy, programmed cell death and targeting m-TOR/PI3K/Akt signalling pathway

Peng Wang, Weiyue Gao, Yibin Wang, Jun Wang; pp 2062-2067 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

Antitumor effects of helenalin in doxorubicin-resistant leukemia cells are mediated via mitochondrial mediated apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and downregulation of PI3-kinase/AKT/m-TOR signalling pathway

Jingxin Liu, Yanan Zhao, Zhangzhen Shi, Yuansong Bai; pp 2068-2074 (Pubmed Abstract, PDF)

Influence of variants in folate metabolism genes on 6-mercaptopurine induced toxicity during treatment for childhood acute lymphocytic leukemia

Goran Milosevic, Nikola Kotur, Jelena Lazic, Nada Krstovski, Biljana Stankovic, Branka Zukic, Dragana Janic, Vladimir Jurisic, Sonja Pavlovic,  Lidija Dokmanovic; pp 2075-2083 (Pubmed Abstract, PDF)

Mantle cell lymphoma: a Turkish Multi-Center Study

Mufide Okay, Ozgur Meletli, Engin Kelkitli, Umit Yavuz Malkan, Mehmet Turgut, Yahya Buyukasik, Fatma Tekin, Haluk Demiroglu,  Hakan Goker; pp 2084-2089 (Pubmed Abstract, PDF)

PROSTATE CANCER

Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial–mesenchymal transition

Yifeng Zhang, Jiong Zhang, Suyu Liang, Genqiang Lang, Gang Liu, Peng Liu, Xiaojun Deng; pp 2090-2098  (Pubmed Abstract, PDF)

SHARP hypofractionated stereotactic radiotherapy for localized prostate cancer: a biochemical response to treatment 

Monika Rucinska, Karolina Osowiecka, Anna Kieszkowska-Grudny, Sergiusz Nawrocki; pp 2099-2106 (Pubmed Abstract, PDF)

Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities

Patra Vezyraki, Angeliki Vlachaki, Dimitrios Baltogiannis, Anna Batistatou, Stavros Tsampalas, Yannis V. Simos, Aris Kaltsas, Periklis Pappas, Evangelia Dounousi, Vasilios Ragos, Evangelos Tsiambas, Dimitrios Peschos; pp 2107-2113 (Pubmed Abstract, PDF)

THYROID CANCER

MicroRNA-15 regulates the proliferation, migration and invasion of thyroid cancer cells by targeting Bcl-2 

Zhongwu Lu, ZhiqiangWu, Jiaqia Hu, Wenjun Wei, Ben Ma, Duo Wen; pp 2114-2119  (Pubmed Abstract, PDF)

The influence of papillary thyroid microcarcinomas size on the occurrence of lymph node metastases

Merima Goran, Ivan Markovic, Marko Buta, Dusica Gavrilovic, Ana Cvetkovic, Nada Santrac, Marija Rakovic, Natasa Medic Milijic, Radan Dzodic; pp 2120-2126 (Pubmed Abstract, PDF)

GISTS

A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII)

Ali Yilmaz, Cem Mirili, Mehmet Bilici, Salim Basol Tekin; pp 2127-2135 (Pubmed Abstract, PDF)

OSTEOSARCOMA

Growth inhibition of Saos-2 osteosarcoma cells by lactucopicrin is mediated via inhibition of cell migration and invasion, sub-G1 cell cycle disruption, apoptosis induction and Raf signalling pathway 

Qing Meng,  Bensen Tang , Bing Qiu; pp 2136-2140 (Pubmed Abstract, PDF)

GLIOBLASTOMA

Antitumor effects of Sweroside in human glioblastoma: its effects on mitochondrial mediated apoptosis, activation of different caspases, G0/G1 cell cycle arrest and targeting JNK/p38 MAPK signal pathways

Zhu Ouyang, Ganqiong Xu; pp 2141-2146 (Pubmed Abstract, PDF)

RENAL CANCER

Outcomes of laparoscopic radical nephrectomy for elderly patients with localized renal cell carcinoma 

Jinnv Liu, Ruifang Song, Hairong Cai, Chan Lu; pp 2147-2154 (Pubmed Abstract, PDF)

MERKEL CELL CARCINOMA

Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma

Igor Richter, Tomas Jirasek, Eva Cermakova, Jiri Bartos, Tomas Büchler, Josef Dvorak; pp 2155-2160 (Pubmed Abstract, PDF)

MELANOMA

A four-gene expression-based signature predicts the clinical outcome of melanoma

Liping Sun, Ping Li, He Ren, Gang Liu; pp 2161-2167 (Pubmed Abstract, PDF)

MENINGIOMA

Antitumor effects of Farnesol in optic nerve sheath meningioma cell line and its effects on cell cycle progression, autophagy, cell migration and invasion

Changhong Zeng, Bo Guo, Jun Chen, Weimin He; pp 2168-2172 (Pubmed Abstract, PDF)

MISCELLANEOUS

Rare tumors: A comprehensive analysis of cancer 

Irina Todor Bondei, Ofelia Suteu, Nicolae Todor, Viorica Magdalena Nagy; pp 2173-2179 (Pubmed Abstract, PDF)

AROME-ESO Oncology Consensus Conference:  Access TO CANCER CARE INNOVATIONS IN COUNTRIES WITH LIMITED RESOURCES. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME–Paris) and European School of Oncology (ESO – Milan)

Vladimir Todorovic, Matti Aapro, Nicholas Pavlidis, Oliver Arsovski,Yazid Belkacemi, Nada Babovic, François Clément Bidard, Mouna Bourhafour, Semir Beslija, Hamouda Boussen, Bojana Cetnikovic,Timur Ceric, Nada Cicmil, Nebojsa Crnogorac, Enkelejda Cuedari, Michele De Laurentis, Tomislav Dragovich, Ivana Durutovic, Zoran Dzamic, Radan Dzodic, Zivka Eri, Fady Geara, Ahmed Khalil, Khaldoun Kerrou, Slavica Knezevic-Usaj, Vladimir Kovcin, Dhurata Koroveshi, Anila Kristo Pema, Abraham Kuten, Jadranka Lakicevic, Nevenka Lukovac, Ivan Markovic, Milan Markovic, Nenad Mijalkovic, Daniela Miladinova, Nikola Milasevic, Giorgio Mustachi, Dragana Ognjenovic, Aleksandra Pantelic, Lazar Popovic, Davorin Radosavljevic, Nina Radosevic, Sinisa Radulovic, Milan Ristevski, Ivana Rosic, Nevena Secen, Milan Sorat, Liljana Stamatovic, Petar Stefanovski, Igor Stojkovski, Dusanka Tesanovic, Zorica Tomasevic, Zoran Tomasevic, Pauletta Tsoutsou, Sedat Turkan, Nino Vasev, Suzana Vasovic, Ferenc Vicko, Damir Vrbanec, Filip Vukmirovic, Eduard Vrdoljak, Bojan Zaric, Jean-Jacques Zambrovski, Franco Cavalli, Joseph Gligorov, on behalf of AROME and ESO; pp 2180-2197 (Pubmed Abstract, PDF)

Comparison of skeletal muscle mass loss in patients with metastatic colorectal cancer treated with regorafenib or TAS-102

Muhammet Bekir Hacioglu, Osman Kostek, Nazmi Kurt, Ahmet Kucukarda, Ali Gokyer, Fethi Emre Ustabasioglu, Fatih Karatas, Nermin Tuncbilek, Sernaz Uzunoglu, Ahmet Bilici, Irfan Cicin, Bulent Erdogan; pp 2198-2204 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Different subtypes of metaplastic breast cancer might have different sensitivity to neoadjuvant chemotherapy 

Kadri Altundag; p 2205 (Pubmed Abstract, PDF)

EGFR amplification and mutations landscape in laryngeal squamous cell carcinoma

Efthymios Kyrodimos, Aristeidis Chrysovergis, Evangelos Tsiambas, Vasileios S.Papanikolaou; p 2205 (Pubmed Abstract, PDF)

Hormone receptor status might be a determinant for HER2 loss after HER2-targeted treatment in HER2 positive breast cancer patients 

Kadri Altundag; p 2206(Pubmed Abstract, PDF)

Chronic antibiotic use for severe acne might increase breast cancer risk

Kadri Altundag; p 2206 (Pubmed Abstract, PDF)

K-RAS mutations in laryngeal squamous cell carcinoma

Vasileios S Papanikolaou, Efthymios Kyrodimos, Evangelos Tsiambas, Aristeidis Chrysovergis; p 2207 (Pubmed Abstract, PDF)

Deciphering trastuzumab resistance in residual tumor according to HER2 status after neoadjuvant trastuzumab containing regimen in HER2 positive breast cancer patients might help to choose further adjuvant anti-HER2 treatment 

Zohrab Abduyev, Kadri Altundag; p 2208 (Pubmed Abstract, PDF)

Reset link sent!

Link for password reset has been emailed to you. Please check your email.